Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Avelumab + Utomilumab + Anti-OX40 + Radiation for Advanced Cancers
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing the side effects of avelumab in combination with utomilumab, anti-OX40 antibody PF-04518600, and radiation therapy in treating patients with advanced malignancies.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service